Table 3.
Chronic Opioid Therapy (COT) Monitoring and Patient Satisfaction With COT Monitoring in a Cohort of People Living with Human Immunodeficiency Virus on COT for Chronic Pain
| Characteristic | Overall | COMM Score ≥9 | COMM Score <9 | P Value |
|---|---|---|---|---|
| (n = 165) | (n = 71) | (n = 94) | ||
| COT monitoring | ||||
| Ever signed opioid treatment agreement at current clinic | 50 (30.3) | 28 (39.4) | 22 (23.4) | .05 |
| Ever had pain medication stopped due to not following rules of agreement | 11 (18.6) | 7 (23.3) | 4 (13.8) | .34 |
| Ever had urine drug test at current clinic | 110 (66.7) | 49 (69.0) | 61 (64.9) | .38 |
| Ever had pill count at current clinic | 20 (12.1) | 11 (15.5) | 9 (9.6) | .25 |
| Received all 3: treatment agreement, urine drug test, and pill count | 8 (4.8) | 6 (8.5) | 2 (2.1) | .08 |
| Patient satisfaction with COT monitoringa | ||||
| Opioid treatment agreement, median (25th, 75th percentile) | 10 (7, 10) | 10 (7, 10) | 10 (7, 10) | .25 |
| Urine drug test, median (25th, 75th percentile) | 10 (8, 10) | 10 (8, 10) | 10 (8, 10) | .93 |
| Pill count, median (25th, 75th percentile) | 10 (6, 10) | 9 (7, 10) | 10 (5, 10) | .81 |
| Ever received naloxone | 17 (10.3) | 7 (9.9) | 10 (10.6) | .87 |
Data are presented as No. (%) unless otherwise indicated.
Abbreviations: COMM, Current Opioid Misuse Measure; COT, chronic opioid therapy.
aSatisfaction (scale of 1–10: 1 = not satisfied at all, 10 = extremely satisfied) was assessed only among the subgroup who had ever received each respective type of monitoring (ie, for the overall group, opioid treatment agreement, n = 51; urine drug test, n = 110; pill count, n = 20).